The invention relates to a drug and specifically relates to a drug compound. The drug compound contains taxus mairei extracts and a pharmaceutically acceptable carrier, wherein the weight percent of the taxus mairei extracts is 0.1-99.9%. The resources of the drug compound are natural; the preparation technique is simple; the toxicity to cells is low; the immunosuppressive action is higher; the application prospect is wide.